ACC/AHA/ESC guidelines for the management of patients with atrial
... AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 ...
... AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 ...
ACC/AHA/ESC Practice Guidelines
... For new or updated text, view the 2011 Focused Update and the 2011 Focused Update on Dabigatran. Text supporting unchanged recommendations has not been updated. It is important that the medical profession play a significant role in critically evaluating the use of diagnostic procedures and therapies ...
... For new or updated text, view the 2011 Focused Update and the 2011 Focused Update on Dabigatran. Text supporting unchanged recommendations has not been updated. It is important that the medical profession play a significant role in critically evaluating the use of diagnostic procedures and therapies ...
ACC/AHA/ESC 2006 guidelines for the management
... AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 ...
... AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 ...
2013 Exercise Standards for Testing and Training
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
AHA guidelines - Boston University Medical Campus
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
Exercise Standards for Testing and Training A Scientific Statement
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
Exercise Standards for Testing and Training A Scientific Statement
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
Exercise Standards for Testing and Training
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
... also can change in response to anemia, metabolic disorders, variable vascular volume or peripheral resistance, or ventricular dysfunction. These conditions themselves do not appear to affect maximal HR unless capacity for exercise intensity becomes limited. Conversely, a lower-than-expected incremen ...
ACC/AHA/ESC Practice Guidelines
... This article has been copublished in the August 15, 2006, issues of Circulation and the Journal of the American College of Cardiology and the September 2006 issue of Europace. Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the Amer ...
... This article has been copublished in the August 15, 2006, issues of Circulation and the Journal of the American College of Cardiology and the September 2006 issue of Europace. Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the Amer ...
ACC/AHA/ESC Practice Guidelines
... 2.1. Atrial Fibrillation . . . . . . . . . . . . . . . . . . . . . . . .e263 2.2. Related Arrhythmias . . . . . . . . . . . . . . . . . . . . . .e263 3. Classification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e263 4. Epidemiology and Prognosis . . . . . . . . . . . . . . . . . ...
... 2.1. Atrial Fibrillation . . . . . . . . . . . . . . . . . . . . . . . .e263 2.2. Related Arrhythmias . . . . . . . . . . . . . . . . . . . . . .e263 3. Classification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e263 4. Epidemiology and Prognosis . . . . . . . . . . . . . . . . . ...
2016 ESC Guidelines for the management of atrial fibrillation
... Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity ...
AHA/ACC/HRS Practice Guideline
... recommendations are effective only if followed. Because lack of patient understanding and adherence may adversely affect outcomes, clinicians should make every effort to engage the patient’s active participation in prescribed medical regimens and lifestyles. In addition, patients should be informed ...
... recommendations are effective only if followed. Because lack of patient understanding and adherence may adversely affect outcomes, clinicians should make every effort to engage the patient’s active participation in prescribed medical regimens and lifestyles. In addition, patients should be informed ...
Task Force Report Guidelines on management (diagnosis and treatment) of syncope*
... A further concern about tests for evaluating the aetiology of syncope is that it is not possible to measure test sensitivity because there is no reference or gold standard for most of the tests employed for this condition. Since syncope is an episodic symptom, a reference standard could be an abnorm ...
... A further concern about tests for evaluating the aetiology of syncope is that it is not possible to measure test sensitivity because there is no reference or gold standard for most of the tests employed for this condition. Since syncope is an episodic symptom, a reference standard could be an abnorm ...
ANTIARRHYTHMIC THERAPY FOR ATRIAL
... Sanfilippo AJ, et al. (36) studied 15 patients who had no evidence of significant structural or functional cardiac abnormalities other than AF. They found that atrial enlargement can occur as a consequence of atrial ...
... Sanfilippo AJ, et al. (36) studied 15 patients who had no evidence of significant structural or functional cardiac abnormalities other than AF. They found that atrial enlargement can occur as a consequence of atrial ...
2016 ESC Guidelines for the management of atrial fibrillation
... Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity ...
8 Proximal Anomalous Connections of Coronary Arteries in Adults
... centre of aortic sinuses. The left coronary ostium may lie near the junction between the left and right aortic sinuses, whereas the right ostium may lie near the junction between the right and the non-coronary aortic sinuses (Muriago et al., 1997). The discrimination between a common variant and an ...
... centre of aortic sinuses. The left coronary ostium may lie near the junction between the left and right aortic sinuses, whereas the right ostium may lie near the junction between the right and the non-coronary aortic sinuses (Muriago et al., 1997). The discrimination between a common variant and an ...
Prognosis of Adults With Borderline Left Ventricular Ejection Fraction
... the risk of developing a composite outcome (heart failure [HF] or death; primary outcome) and incident HF (secondary outcome). RESULTS During follow-up (median 7.9 years), HF developed in 355 participants, and 1,070 died. Among participants with an LVEF of 50% to 55% (prevalence 3.5%), rates of the ...
... the risk of developing a composite outcome (heart failure [HF] or death; primary outcome) and incident HF (secondary outcome). RESULTS During follow-up (median 7.9 years), HF developed in 355 participants, and 1,070 died. Among participants with an LVEF of 50% to 55% (prevalence 3.5%), rates of the ...
PROMUS Element™ Plus
... Contents supplied STERILE using an ethylene oxide (EO) process. Do not use if sterile barrier is damaged. If damage is found, call your Boston Scientific representative. For single use only. DO NOT REUSE, REPROCESS OR RESTERILIZE. Reuse, reprocessing or resterilization may compromise the structural ...
... Contents supplied STERILE using an ethylene oxide (EO) process. Do not use if sterile barrier is damaged. If damage is found, call your Boston Scientific representative. For single use only. DO NOT REUSE, REPROCESS OR RESTERILIZE. Reuse, reprocessing or resterilization may compromise the structural ...
Pacing Therapies for Heart Failure (PDF Available)
... functions of these devices, covering the indications for their use and common problems encountered with this technology, in a logical, evidence-based manner. We have also taken a “how-to-do-it” approach for certain areas of implantable device function. The inclusion of these sections will be of inte ...
... functions of these devices, covering the indications for their use and common problems encountered with this technology, in a logical, evidence-based manner. We have also taken a “how-to-do-it” approach for certain areas of implantable device function. The inclusion of these sections will be of inte ...
the left atrium in hypertension: a symbol of mortality and morbidity?
... There may also be an interaction between left atrial pathophysiology and arterial hypertension, one of the commonest risk factors for cardiovascular disease and stroke? Conflicting data exist regarding the influence of blood pressure on left atrial size. The Framingham study [20] demonstrated that i ...
... There may also be an interaction between left atrial pathophysiology and arterial hypertension, one of the commonest risk factors for cardiovascular disease and stroke? Conflicting data exist regarding the influence of blood pressure on left atrial size. The Framingham study [20] demonstrated that i ...
TAXUS I, II SR, IV, and V
... the TAXUS clinical trials analyzed to date, the differences in the incidence of stent thrombosis observed with the TAXUS Stent compared to bare-metal stents have not been associated with an increased risk of cardiac death, myocardial infarction, or all-cause mortality. Additional data from longer-te ...
... the TAXUS clinical trials analyzed to date, the differences in the incidence of stent thrombosis observed with the TAXUS Stent compared to bare-metal stents have not been associated with an increased risk of cardiac death, myocardial infarction, or all-cause mortality. Additional data from longer-te ...
Catheter Ablation as Treatment for Atrial Fibrillation
... variety of supraventricular arrhythmias, in which intracardiac mapping identifies a discrete arrhythmogenic focus that is the target of ablation (see the Catheter Ablation for Cardiac Arrhythmias Protocol). The situation is more complex for AF, because there is no single arrhythmogenic focus. Since ...
... variety of supraventricular arrhythmias, in which intracardiac mapping identifies a discrete arrhythmogenic focus that is the target of ablation (see the Catheter Ablation for Cardiac Arrhythmias Protocol). The situation is more complex for AF, because there is no single arrhythmogenic focus. Since ...